KOMBINATIONSTHERAPIE
European patent · EP3843748 · In force
Register entry
- Publication number
- EP3843748
- Application number
- EP19762358
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Aug 30, 2019
- Published
- Jul 7, 2021
- Granted
- Jun 25, 2025
- Protection ends at the latest
- Aug 29, 2039
- Next annual fee due
- Aug 31, 2027
- IPC classes
- A61K 31/635 (2006.01)A61K 45/06 (2006.01)A61K 47/68 (2017.01)A61P 35/00 (2006.01)
- Priority
- GB 201814207 31.08.2018GB 201908225 10.06.2019
- PCT application
- PCT/EP2019/073212 30.08.2019
- PCT publication
- WO2020/043878 05.03.2020
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.08.2026 → 31.08.2027
Published in Swissreg on 01.09.2026
- Aug 13, 2026
Pledge entered
- Pledgee
- Owl Rock Opportunistic Master Fund I, L.P., 399 Park Avenue - 38th Floor, New York, NY10022, USA
Published in Swissreg on 13.08.2026
- May 7, 2026
Change
Published in Swissreg on 07.05.2026
- Sep 18, 2025
Agent entered
- Representative
- MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex
Published in Swissreg on 18.09.2025
- Sep 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.08.2025 → 31.08.2026
Published in Swissreg on 01.09.2025
- Jun 25, 2025
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 25.06.2025
- Jun 25, 2025
Change
Published in Swissreg on 25.06.2025
Parties
Holder
Pledgee
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.